Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Cook Medical gets FDA approval for aortic dissection device

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

DataOne and InterSystems Lay the Digital...

Connecting hospitals and insurers through an integrated data bridge...

InterSystems Honored with Four 2026 Best...

Recognized for excellence in Acute Care EHR and Shared...

InterSystems Payer Connector debuts on the...

New solution establishes a governed integration engine to accelerate...

Cook Medical announced its recent approval from the U.S. FDA for its Zenith Dissection Endovascular System. The system, consisting of a proximal stent-graft component and a distal bare stent component, provides physicians a less invasive alternative to open surgery for repair of Type B dissections of the descending thoracic aorta. The device will be available for sale in the U.S. in the coming months.

“We’re pleased to provide another minimally invasive option for aortic repair,” said Mark Breedlove, vice president of Cook Medical’s Vascular division. “The approval of this product gives us an opportunity to have a positive impact on the lives of patients with aortic dissections.”

Aortic dissection is a tear that occurs between the innermost and middle layers of the aorta. When the inner layer of the aorta tears, blood flows through the tear, which causes the inner and middle layers of the aorta to separate (dissect). Type B dissection involves a tear in the lower (descending) aorta, while Type A dissection involves a tear in the upper (ascending) aorta.

Globally, thoracic endovascular aortic repair (TEVAR) is acknowledged as the treatment of choice for complicated Type B aortic dissection. These procedures are meant to prevent malperfusion of aortic branches and aortic rupture.

“Cook Medical is committed to developing a variety of treatment options for aortic disease – from the arch to the iliacs, in order to help physicians fit a device to each patient’s unique disease state,” Breedlove said.

To learn more about Cook’s disease-specific treatment options for endovascular repair, visit aortic.cookmedical.com.

About Cook Medical
Since 1963 Cook Medical has worked closely with physicians to develop technologies that eliminate the need for open surgery. Today we are combining medical devices, biologic materials and cellular therapies to help the world’s healthcare systems deliver better outcomes more efficiently. We have always remained family owned so that we have the freedom to focus on what we care about: patients, our employees and our communities.

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

DataOne and InterSystems Lay the Digital Foundation for AI-Ready Health Insurance in Thailand

Connecting hospitals and insurers through an integrated data bridge...

InterSystems Honored with Four 2026 Best in KLAS Awards

Recognized for excellence in Acute Care EHR and Shared...

InterSystems Payer Connector debuts on the Epic Showroom

New solution establishes a governed integration engine to accelerate...

InterSystems Appoints Don Woodlock as President

Boston, MA – January 6, 2026 – InterSystems, a creative...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »